Home/Filings/4/0001429216-26-000002
4//SEC Filing

ZEHNDER WILLIAM TODD 4

Accession 0001429216-26-000002

CIK 0001729149other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 5:02 PM ET

Size

18.8 KB

Accession

0001429216-26-000002

Research Summary

AI-generated summary of this filing

Updated

Viemed Healthcare COO William Zehnder Exercises and Sells Shares

What Happened William (Todd) Zehnder, COO of Viemed Healthcare (VMD), had several equity‑related transactions tied to vesting and settlement of derivative awards on Jan 17, 2026 and received new awards on Jan 19, 2026. On Jan 17 he recorded exercises/conversions of phantom/derivative awards that resulted in (a) 8,550 shares withheld by the company to satisfy tax obligations at $7.33/share (cash value $62,672) and (b) 6,735 shares disposed back to the issuer at $7.33/share (cash value $49,368). Combined cash proceeds/settlements reported for those dispositions are about $112,040. On Jan 19 he was granted new awards: 118,759 RSUs and 29,690 phantom share units (total 148,449 units), each vesting in three equal annual installments beginning on the first anniversary of the grant.

Key Details

  • Transaction dates: Jan 17, 2026 (vesting/settlement); Jan 19, 2026 (new grants). Filing date: Jan 21, 2026.
  • Reported dispositions related to tax withholding: 8,550 shares @ $7.33 = $62,672; disposition to issuer: 6,735 shares @ $7.33 = $49,368. Total ≈ $112,040.
  • New awards: 118,759 RSUs (F7) and 29,690 phantom share units (F9), both vest in three equal annual installments. Per‑share values use the market close on Jan 16, 2026 (F3).
  • Footnotes: F2 = shares withheld for taxes; F4 = phantom shares are cash‑settled (economic equivalent of one share); F5/F6/F7/F9 = vesting schedules for RSUs/phantoms.
  • Shares owned after the transactions are not specified in the excerpted data. The filing covers Jan 17 transactions and was submitted Jan 21, 2026 (see filing for any timeliness statements).

Context

  • These transactions appear to be compensation‑related (RSU vesting and cash settlement of phantom units) rather than open‑market buys or discretionary sells. The phantom shares were cash‑settled—reported as acquisition/disposition of underlying shares and simultaneous disposition to the company for cash (F4).
  • Tax withholding (F2) is routine when RSUs vest and does not necessarily indicate a change in insider sentiment.
  • For retail investors: such filings commonly reflect standard compensation processing. Purchases would be more notable as a bullish signal; these entries are largely administrative settlements and new grant awards.

Insider Transaction Report

Form 4
Period: 2026-01-17
ZEHNDER WILLIAM TODD
DirectorChief Operating Officer
Transactions
  • Exercise/Conversion

    Common Shares

    [F1]
    2026-01-17+26,939300,912 total
  • Tax Payment

    Common Shares

    [F2][F3]
    2026-01-17$7.33/sh8,550$62,672292,362 total
  • Exercise/Conversion

    Common Shares

    [F4]
    2026-01-17+6,735299,097 total
  • Disposition to Issuer

    Common Shares

    [F3]
    2026-01-17$7.33/sh6,735$49,368292,362 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F5]
    2026-01-1726,9390 total
    Exp: 2026-01-17Common Shares (26,939 underlying)
  • Exercise/Conversion

    Phantom Share Units

    [F4][F6]
    2026-01-176,7350 total
    Exp: 2026-01-17Common Shares (6,735 underlying)
  • Award

    Restricted Stock Units

    [F1][F7]
    2026-01-19+118,759118,759 total
    Exp: 2029-01-19Common Shares (118,759 underlying)
  • Award

    Phantom Share Units

    [F8][F9]
    2026-01-19+29,69029,690 total
    Exp: 2029-01-19Common Shares (29,690 underlying)
Footnotes (9)
  • [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
  • [F2]Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
  • [F3]Per share value is based on the market closing price of the common shares for January 16, 2026.
  • [F4]Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
  • [F5]Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
  • [F6]Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
  • [F7]Restricted Stock Units (RSUs) granted to reporting person on January 19, 2026, which vest in three equal annual installments beginning on the first anniversary of the grant date.
  • [F8]Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
  • [F9]Represents an award granted on January 19, 2026 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Signature
/s/ Jesse Bergeron, Attorney-in-Fact|2026-01-21

Issuer

VIEMED HEALTHCARE, INC.

CIK 0001729149

Entity typeother

Related Parties

1
  • filerCIK 0001429216

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 5:02 PM ET
Size
18.8 KB